Psychiatr. pro Praxi, 2002; 2: 64-68

Deprese v perimenopauze - algoritmy léčby

doc. MUDr. Vladimír Pidrman Ph.D, prof. MUDr. Jaroslav Bouček CSc
Psychiatrická klinika FN a LF UP, Olomouc

Published: December 31, 2002  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pidrman V, Bouček J. Deprese v perimenopauze - algoritmy léčby. Psychiatr. praxi. 2002;3(2):64-68.

Statistické odhady Světové zdravotnické organizace ukazují, že v roce 2030 dosáhne věkové hranice padesáti let 1,2 miliardy žen. Ty stráví nejen několik následujících dekád svého života v menopauze, ale také přibližně 4-8 let v přecházejícím období - v perimenopauze. S tím souvisí požadavek minimalizace výskytu nemocí a dalších zdravotních komplikací, které přímo nebo zprostředkovaně souvisí s věkem perimenopauzy a následné menopauzy. Řešení otázky komfortu a zdraví ženy v tomto období by proto mělo být komplexním úkolem pro širší lékařskou veřejnost, nejen pro gynekology, ale i pro psychiatry a praktické lékaře.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Angst J. Premenstrual dysphoria. Eur Neuropsychopharmacology 1999; 9: 144. Go to original source...
    2. Bach-y-Rita P. Psychopharmacologic drugs: Mechanism of action. Science, 1994; 264: 642-644. Go to original source...
    3. Bazire S. Psychotropic drug directory 2000: the professionals´ pocket handbook and aide memoire. Mark Allen Publishing Ltd 2000: 324.
    4. Bennet CJ, Plum F. Cecil textbook of medicine. 20-th. edition. Philadelphia, W. B. Saunders Comp 1996: 2233.
    5. Belchety PW. Hormonal treatment of postmenopausal women. N Engl J Med 1994; 330: 1062-1071. Go to original source... Go to PubMed...
    6. Briley M. Is full recovery from depression possible? London, Martin Dunitz, Ltd 1998: 54. Go to original source...
    7. Burt VK, Hendrick VC. Women´s mental health. Washington, DC, American Psychiatric Press 1997: 168.
    8. Carlson K, Miller B. Outcomes of hysterectomy. Clin Obstet Gynecol 1997; 40, 4: 945. Go to original source... Go to PubMed...
    9. Davies A, Magos A. Indications and alternatives to hysterectomy. Clin Obstet Gynecol 1997; 11, 1: 61-75. Go to original source... Go to PubMed...
    10. Eriksson E. Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria. Int Clin Psychopharmacol 1999; 14 (suppl. 2): 27-33.
    11. Freeman EW, Rickels K, Sondheimer SJ, et al. Differential response to antidepressants in women with premenstrual syndrome / premenstrual dysphoric disorder. Arch Gen Psychiatry 1999; 56: 932-939. Go to original source... Go to PubMed...
    12. Hay AG, Bancroft J, Johnstone EC. Affestive symptoms in women menopause clinic. Br J Psychiatry 1994; 164: 513-516. Go to original source... Go to PubMed...
    13. Holsboer-Trachsler E. Sind Frauen haufiger depressiv? AD revue 2000; 6, 1: 3-9.
    14. McKinney K, Thompson W. A practical guide to prescribing hormone replacement therapy. Drugs 1998; 56: 49-57. Go to original source... Go to PubMed...
    15. Montgomery SA, den Boer JA. SSRIs in depression and anxiety. Chichester, John Wiley and sons, Ltd 1998: 194.
    16. Pidrman V. Deprese v perimenopauze. Praha, Galén, Lubomír Houdek 2001: 32.
    17. Pidrman V, Látalová K. Premenstuální dysforická porucha. Psychiatrie pro praxi 2, 2001; 2: 58-61.
    18. Preskorn SH. Clinical pharmacology of selective serotonin reuptake inhibitors. Caddo, Professional Communications, Inc 1996: 255.
    19. Preskorn SH. Outpatient management of depression. reuptake inhibitors. Caddo, Professional Communications, Inc 1999: 256.
    20. Raboch J. Psychosexuální adaptace žen po některých gynekologických operacích. Cas Lék Ces 1992; 131, 8: 255.
    21. Raboch J. Můžeme vyléčit depresi? Galén, Praha 2000: 32.
    22. Rapkin A, Laughlin D. Guidelines for the treatment of premenstrual syndrome. Fam Prac Recent 1999; 21: 51.
    23. Roca CA. Estrogen and mood in perimenopausal women. Mood and psychotic disorders in women: an update on treatment. APA educational program, Washington, DC, APA, 1999: 52-61.
    24. Roca CA. Mood, hormones and menopause. Reproductive psychiatry: an update on womens heath. APA educational program, Chicago, Scientific therapeutics information, inc., 2000: 44-51.
    25. Rubinow DR. Effects of gonadal steroids on brain and behavior. APA educational program, Chicago, APA, 2000: 9-19.
    26. Rubinow DR, Schmidt PJ, Roca CA. Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry, 1998; 44: 839-850. Go to original source... Go to PubMed...
    27. Robertson MM, Katona CLE. Depression and physical illness. John Wiley and Sons Ltd. Chichester, West Sussex 1997: 564.
    28. Schatzberg AF, DeBattista Ch, Overman GP, Ereshevsky L. The 1998 black book of psychotropic dosing and monitoring. New York, MBL Communications, Inc 1998: 40.
    29. Sherwin BB. Hormones, mood and cognitive functioning in postmenopausal women. Obstet Gynecol 1996; 87, suppl.: 20-26. Go to original source... Go to PubMed...
    30. Shiloh R, Nutt D, Weizman A. Atlas of psyciatric pharmacotherapy. London, Martin Dunitz Ltd, 2000: 236.
    31. Stahl SM. Psychopharmacology of antidepressants. London, Martin Dunitz, Ltd, 1998: 114.
    32. Stahl SM. Basic psychopharmacology of antidepressants. Part 2: Estrogen as an adjunct to antidepressant tretment. Clin. Psychiatry, 1998; 59 (suppl. 4): 15-24.
    33. Stahl SM. Sex therapy in psychiatric treatment has a new partner: reproductive hormones. J Clin Psychiatry 1997; 58: 468-469. Go to original source... Go to PubMed...
    34. Steiner M, Yonkers K. Depression in women. London, Martin Dunitz Ltd, 1999; 102.
    35. Viguera AC. SSRIs in the treatment of PMDD: a critical review. Advances in womens mental health: a decade of progress. Educational program APA, Chicago, APA, 2000: 21-35.
    36. Weissman MM, Bland RC, Canino GJ. Cross-national epidemiology of major depression and bipolar disorder. JAMA, 1996; 276, 4: 293-299. Go to original source...
    37. Wickelgren I. Estrogen stakes claim to cognition. Science, 1997; 276: 675-678. Go to original source... Go to PubMed...
    38. Yonkers K. The association between premenstrual dysphoric disorder and other mood disorder. J Clin Psychiatry 1997; 58 (suppl. 15): 19-25.
    39. Zweifel JE, O Brien WH. A meta-analysis of the effect of hormone replacement therapy upon depresses mood. Psychoneuroendocrinology, 1997; 22: 189-212. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.